Nicaragua vs South-East Asia (WHO region): HIV-positive TB patients on ART (antiretroviral therapy)

Nicaragua
100.0%
in 2023
South-East Asia (WHO region)
94.0%
in 2024
Nicaragua rank
1st
South-East Asia (WHO region) rank
4th

HIV-positive TB patients on ART (antiretroviral therapy) over time

  • Nicaragua
  • South-East Asia (WHO region)
020406080100200320132024

How they compare

Nicaragua currently reports 100.0% against 94.0% in South-East Asia (WHO region), a difference of 6.0%.

That makes Nicaragua's figure about 1.1 times South-East Asia (WHO region)'s.

Across all 14 years both countries report, Nicaragua has been ahead every year.

Nicaragua ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.

Nicaragua has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Nicaragua South-East Asia (WHO region) Difference Ahead
2000s 97.0% 45.5% 51.5% Nicaragua
2010s 87.4% 74.5% 12.9% Nicaragua
2020s 98.2% 91.8% 6.5% Nicaragua

Averages of every year both report within each decade.

Frequently asked questions

Which has higher hiv-positive tb patients on art (antiretroviral therapy), Nicaragua or South-East Asia (WHO region)?
Nicaragua, at 100.0% against 94.0% in South-East Asia (WHO region) as of 2023.
What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Nicaragua and South-East Asia (WHO region)?
6.0%, with Nicaragua ahead.
How many years of comparable data are there for Nicaragua and South-East Asia (WHO region)?
14 years are reported by both, from 2008 to 2023.
How do Nicaragua and South-East Asia (WHO region) rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
Nicaragua ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Nicaragua vs South-East Asia (WHO region): HIV-positive TB patients on ART (antiretroviral therapy). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 18 September 2026, from https://health.statizoid.com/compare/hiv-positive-tb-patients-on-art-antiretroviral-therapy-percent/nicaragua/south-east-asia-who-region/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/hiv-positive-tb-patients-on-art-antiretroviral-therapy-percent/nicaragua/south-east-asia-who-region/">Nicaragua vs South-East Asia (WHO region): HIV-positive TB patients on ART (antiretroviral therapy)</a> — Statizoid

About this data

Indicator
HIV-positive TB patients on ART (antiretroviral therapy) (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
157 places, 2,569 data points, 2003–2024
Last refreshed